← FDA Drug Approvals (Drugs@FDA)

YCANTH

NDA · New Drug Application · Sponsor: VERRICA PHARMS · Approved 2023-07-21

Drug application

FDA Application #

NDA212905

Application type

New Drug Application

Brand name

YCANTH

Generic name

CANTHARIDIN

Active ingredients

CANTHARIDIN

Dosage form

SOLUTION

Route

TOPICAL

Marketing status

Prescription

Sponsor

VERRICA PHARMS

Manufacturer

Verrica Pharmaceuticals Inc.

First approval

2023-07-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown